经皮腔内静脉介入联合抗凝与单纯抗凝治疗近端深静脉血栓患者的比较:一项荟萃分析与系统评价
该系统评价与荟萃分析纳入4项随机对照试验,比较经皮腔内静脉介入(PEVI)联合标准抗凝与单纯抗凝治疗下肢近端深静脉血栓的效果。结果显示联合治疗降低血栓后综合征、静脉阻塞和复发性深静脉血栓发生率,提高6个月和12个月髂股静脉通畅率,但导管导向溶栓组大出血事件更多。
要点
- PEVI联合抗凝较单纯抗凝降低血栓后综合征发生率(OR 0.34,95%CI 0.18-0.63)。
- 联合治疗提高6个月和12个月髂股静脉通畅率(OR 8.49,95%CI 1.32-54.60)。
- 导管导向溶栓组大出血事件更多(Peto OR 5.86,95%CI 1.76-19.48)。
核心结论
- PEVI联合抗凝降低血栓后综合征、复发性深静脉血栓和静脉阻塞的发生率,提高6个月和12个月通畅率,但增加大出血事件。
研究设计与样本
- 系统检索PubMed、Embase和Cochrane Library自建库至2016年5月的随机对照试验,最终纳入4项RCT,采用随机效应模型汇总数据。
主要发现
- PEVI联合标准抗凝与单纯抗凝相比,血栓后综合征发生率更低(OR 0.34,95%CI 0.18-0.63)。
- 联合治疗组6个月和12个月髂股静脉通畅率显著更高(OR 8.49,95%CI 1.32-54.60)。
- 联合治疗组静脉阻塞发生率更低(OR 0.42,95%CI 0.20-0.924)。
- 联合治疗组复发性深静脉血栓发生率更低(OR 0.42,95%CI 0.20-0.92)。
- 导管导向溶栓组大出血事件更多(Peto OR 5.86,95%CI 1.76-19.48)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Combination treatment with percutaneous endovenous intervention (PEVI) and anticoagulation has been proposed for treating lower-extremity proximal deep vein thrombosis (DVT). We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the effect of PEVI plus anticoagulation versus anticoagulation alone in patients with lower-extremity proximal DVT. METHODS: We systematically searched PubMed, Embase, and the Cochrane Library from inception to May 2016. All RCTs comparing clinical outcomes between additional PEVI and anticoagulation alone were included. The main end points were postthrombotic syndrome (PTS) and major bleeding complications. Secondary outcomes included the iliofemoral patency rate, venous obstruction, and recurrent DVT. We assessed pooled data using a random-effects model. RESULTS: Four RCTs were included. PEVI plus standard anticoagulation compared with anticoagulation alone was associated with a lower rate of PTS (odds ratio [OR] 0.34, 95% confidence interval [CI] 0.18-0.63), significantly higher iliofemoral patency rate at 6 months and 12 months (OR 8.49, 95% CI 1.32-54.60), a lower rate of venous obstruction (OR 0.42, 95% CI 0.20-0.924), and a lower rate of recurrent DVT (OR 0.42, 95% CI 0.20-0.92). However, more major bleeding episodes occurred in the group with catheter-directed thrombolysis (Peto OR 5.86, 95% CI 1.76-19.48). CONCLUSIONS: PEVI plus anticoagulation reduced the occurrence of PTS, recurrent DVT, and venous obstruction. Another advantage is an increased patency rate at 6 and 12 months. The disadvantage is an increased occurrence of major bleeding events.
引用
- Wang CN, Deng HR. Percutaneous Endovenous Intervention Plus Anticoagulation versus Anticoagulation Alone for Treating Patients with Proximal Deep Vein Thrombosis: A Meta-analysis and Systematic Review. Ann Vasc Surg. 2018. PMID: 29454036. doi:10.1016/j.avsg.2017.09.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。